Trial Outcomes & Findings for Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD") (NCT NCT00747461)

Results Overview

Recruitment status

TERMINATED

Study phase

PHASE4

Target enrollment

5 participants

Primary outcome timeframe

30 days

Results posted on

2015-08-18

Participant milestones
Measure	Cryo Spray Ablation subjects receiving up to 4 -5 second spray cycles
Overall Study STARTED	5
Overall Study COMPLETED	0
Overall Study NOT COMPLETED	5

Reasons for withdrawal
Measure	Cryo Spray Ablation subjects receiving up to 4 -5 second spray cycles
Overall Study study terminated by sponsor	5

Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")

Baseline characteristics by cohort
Measure	Cryo Spray Ablation n=5 Participants subjects will receive up to 4 -5 second cycles of cryospray ablation
Age, Categorical <=18 years	0 Participants n=99 Participants
Age, Categorical Between 18 and 65 years	3 Participants n=99 Participants
Age, Categorical >=65 years	2 Participants n=99 Participants
Sex: Female, Male Female	3 Participants n=99 Participants
Sex: Female, Male Male	2 Participants n=99 Participants
Region of Enrollment United States	5 participants n=99 Participants

Timeframe: 30 days

Population: study terminated by Sponsor-data not analyzed

Outcome data not reported

Timeframe: 12 months

Population: study terminated-no subjects analyzed.

need for additional treatments within specified period

Outcome data not reported

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Adverse event data not reported

Adverse event data not reported

CSA Medical

Phone: 781-538-4732